Biological drug products
By: Wang, Wei.
Contributor(s): Singh, Manmohan.
Publisher: Sussex 2015Edition: 1st.Description: 728 Pages | Binding - Paperback |.ISBN: 978-1-118-14889-1.Subject(s): PHARMACEUTICSDDC classification: 615.19 Online resources: Click here to access online Summary: This book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs –– a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues. Following this opening, the major classes of biologics are discussed: proteins and peptides, vaccines, oligonucleotides, and gene and regenerative medicines. A concluding section details administration and delivery routes and systems. The book incorporates both lessons learned and future directions to make for a valuable resource and reference for pharmaceutical scientists involved in the dynamic field of biologics.Item type | Current location | Collection | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|---|---|
Text Books | School of Pharmacy Reference Section | Reference | 615.19 WAN/SIN (Browse shelf) | Not For Loan | B2923 |
Browsing School of Pharmacy Shelves , Shelving location: Reference Section , Collection code: Reference Close shelf browser
No cover image available | ||||||||
615.19 VAR/HRU Synthesis of essential drugs | 615.19 VEE Structure based drug design | 615.19 WAL Textbook of medicinal chemistry - II | 615.19 WAN/SIN Biological drug products | 615.19 WAR Practice of medicinal chemistry | 615.19 WES Solid state chemistry and its applications | 615.19 WIL/GIS Wilsons and Gisvolds textbooks of organic medicinal and pharmaceutical chemistry |
This book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs –– a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues. Following this opening, the major classes of biologics are discussed: proteins and peptides, vaccines, oligonucleotides, and gene and regenerative medicines. A concluding section details administration and delivery routes and systems. The book incorporates both lessons learned and future directions to make for a valuable resource and reference for pharmaceutical scientists involved in the dynamic field of biologics.
There are no comments for this item.